CAR-T therapy is a major advance in cancer care, but high costs and centralized global manufacturing limit access.
The production of red blood cells from stem cells has emerged as a transformative approach to address chronic blood shortages and meet the increasing demand for transfusion therapies. By harnessing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback